Abstract
At least 25–30 % of patients with cancer and even a higher percentage of those in an advanced phase of illness meet the criteria for a psychiatric diagnosis, including depression, anxiety, stress-related syndromes, including severe adjustment disorders, sleep disorders, and delirium. A number of studies in psycho-oncology have accumulated over the last 35 years on the use of psychotropic drugs as a pillar in the treatment of psychiatric disorders. Major advances in research have also shown the efficacy of psychotropic drugs as adjuvant treatment of cancer-related symptoms, such as pain, hot flashes, pruritus, nausea and vomiting, fatigue, and cognitive impairment. The knowledge about pharmacokinetics and pharmacodynamics, clinical use, safety, side effects, and efficacy of drugs in cancer care is essential. The aims of this chapter are to consider the need for an integrated psychological and psychopharmacological intervention, as the concept of psychopharmoncology specifies, favoring the vision of an integrated and multidimensional approach in oncology, and palliative care services as well as in community-based cancer centers. Open image in new window
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
